A carregar...
Impact of siltuximab on patient-related outcomes in multicentric Castleman’s disease
Multicentric Castleman’s disease (MCD) is a rare, widespread lymphoproliferative disorder and a life-threatening disease involving hyperactivity of the immune system, excessive proinflammatory cytokine release, immune cell proliferation, and organ system dysfunction. Interleukin-6 (IL-6) is a cytoki...
Na minha lista:
| Publicado no: | Patient Relat Outcome Meas |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5769562/ https://ncbi.nlm.nih.gov/pubmed/29391839 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PROM.S140011 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|